SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001104659-23-027656 from EQRx, Inc. (CIK 0001843762)

EQRx, Inc. (CIK 0001843762)
Date: March 2, 2023 · CIK: 0001843762 · Accession: 0001104659-23-027656

AI Filing Summary & Sentiment

File numbers found in text: 333-269973

Date
March 2, 2023
Author
EQRX
Form
CORRESP
Company
EQRx, Inc. (CIK 0001843762)

Letter

EQRX, INC.

Hampshire Street

Cambridge MA 02139

VIA EDGAR

March 2, 2023

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

Re: EQRx, Inc.

Acceleration Request for Registration Statement on Form S-3

Filed February 23, 2023

File No. 333-269973

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, EQRx, Inc. hereby requests that the effective date and time of the above-referenced registration statement be accelerated to March 3, 2023, at 4:30 p.m., Eastern Time, or as soon thereafter as practicable.

If you have any questions regarding this request, please contact William Collins of Goodwin Procter LLP at (617) 570-1447.

Sincerely,
EQRX,
INC.

Show Raw Text
CORRESP
1
filename1.htm

EQRX,
INC.

50
Hampshire Street

Cambridge
MA 02139

VIA
EDGAR

March 2, 2023

United States
Securities and Exchange Commission

Division of
Corporation Finance

100 F Street,
N.E.

Washington,
DC 20549

Re: EQRx,
Inc.

Acceleration
Request for Registration Statement on Form S-3

Filed February
23, 2023

File No.
333-269973

Ladies and
Gentlemen:

Pursuant to
Rule 461 under the Securities Act of 1933, as amended, EQRx, Inc.  hereby requests that the effective date and time of the above-referenced
registration statement be accelerated to March 3, 2023, at 4:30 p.m., Eastern Time, or as soon thereafter as practicable.

If you have
any questions regarding this request, please contact William Collins of Goodwin Procter LLP at (617) 570-1447.

    Sincerely,

    EQRX,
    INC.

    /s/ Jami Rubin

    Jami
    Rubin

    Chief
    Financial Officer

cc: Melanie
Nallicheri, EQRx, Inc.

Dina Ciarimboli, EQRx, Inc.

William Collins,
Goodwin Procter LLP

Marianne Sarrazin,
Goodwin Procter LLP